Immunohistology of Endocrine Tumors

Diagnostic Immunohistochemistry, Second Edition

Volumn , Issue , 2006, Pages 261-300

  DeLellis, Ronald A ^a,b   Shin, Sandra J ^c  

^a Pathology and Laboratory Medicine   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902398568     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06652-8.50015-6     Document Type: Chapter

References (313)

1. RA DeLellis and HJ Wolfe (1987) Contributions of immunohistochemical and molecular biological techniques to endocrine pathology. J Histochem Cytochem 35 1347-1351.
2. RA DeLellis (1995) Endocrine tumors. RB Colvin, AK Bhan, RT McCluskey (Eds) Diagnostic immunopathology New York: Raven Press 551-578.
3. RA DeLellis and HJ Wolfe (1991) Analysis of gene expression in endocrine cells. CM Fenoglio-Preiser, CL Williman (Eds) Molecular diagnostics in pathology Baltimore: Williams & Wilkins 299-323.
4. RV Lloyd, L Jin, E Kulig, et al. (1992) Molecular approaches for the analysis of chromogranins and secretogranins. Diagn Mol Pathol 1 2-15.
5. GM Portela-Gomes, M Stridsberg, L Grimelius, et al. (2000) Expression of five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem 8 126-132.
6. RA DeLellis and AS Tischler (1998) The dispersed neuroendocrine cell system. K Kovacs, SL Asa (Eds) Functional endocrine pathology Oxford: Blackwell Science 529-549.
7. JM Lauweryns and L Van Ranst (1988) Immunocytochemical localization of aromatic l-amino acid decarboxylase in human, rat and mouse bronchopulmonary and gastrointestinal endocrine cells. J Histochem Cytochem 36 1181-1186.
8. RV Lloyd, JC Sisson, B Shapiro, et al. (1986) Immunohistochemical localization of epinephrine, norepinephrine, catecholaminesynthesizing enzymes and chromogranin in neuroendocrine cells and tumors. Am J Pathol 125 45-54.
9. RV Lloyd, L Jin, X Qian, et al. (1995) Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries. Am J Pathol 146 1188-1198.
10. L Scopsi, M Gullo, F Rilke, et al. (1995) Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic tissues: Their use as markers of neuroendocrine differentiation. J Clin Endocrinol Metab 80 294-301.
11. L Scopsi, R Lee, M Gullo, et al. (1998) Peptidylglycine, an amidating monooxygenase in neuroendocrine tumors: Its identification, characterization, quantification and relation to the grade of morphologic differentiation, amidated peptide content and granin immunocytochemistry. Appl Immunohistochem 6 120-132.
12. D Schmechel, PJ Marangos and M Brightman (1978) Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 276 834-836.
13. H Haimoto, Y Takahashi, T Koshikawa, et al. (1985) Immunohistochemical localization of gamma enolase in normal human tissues other than nervous and neuroendocrine tissue. Lab Invest 52 257-263.
14. DE Schmechel (1985) Gamma submit of the glycolytic enzyme enolase: Nonspecific or neuron specific? Lab Invest 52 239-242.
15. B Seshi, L True, D Carter, et al. (1988) Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase. Am J Pathol 131 258-269.
16. J Rode, AP Dillon, JF Doran, et al. (1985) PGP 9.5, a new marker for human neuroendocrine tumors. Histopathology 9 147-158.
17. GL Li, M Farooque, A Holtz, et al. (1997) Expression of the ubiquitin carboxyl-terminal hydrolase PGP 9.5 in axons following spinal cord compression trauma. APMIS 105 384-390.
18. PO Wilson, PC Barber, QA Hamid, et al. (1988) The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol 69 91-104.
19. C Bordi, FP Pilato and T D'Adda (1988) Comparative study of several neuroendocrine markers in pancreatic endocrine tumors. Virchows Arch A Pathol Anat Histopathol 413 387-398.
20. E Tezel, K Hibi, T Nagasaka, et al. (2000) PGP9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res 6 4764-4767.
21. G Mendelsohn (1981) Histaminase localization in medullary thyroid carcinoma and small cell lung carcinoma. RA DeLellis (Eds) Diagnostic immunohistochemistry New York: Masson 299-312.
22. H Sasano, JI Mason and N Sasano (1989) Immunohistochemical analysis of cytochrome P450 17 alpha in human adrenocortical disorders. Hum Pathol 20 113-117.
23. H Sasano, M Okamoto and N Sasano (1988) Immunohistochemical study of cytochrome P-450 11β hydroxylase in human adrenal cortex with mineralo- and glucocorticoid excess. Virchows Arch A Pathol Anat Histopathol 413 313-318.
24. H Sasano, M Okamoto, JI Mason, et al. (1989) Immunohistochemical studies of steroidogenic enzymes (aromatase, 17 alpha-hydroxylase and cholesterol side chain cleavage cytochrome P450) in sex cord stromal tumors of the ovary. Hum Pathol 20 452-457.
25. RV Lloyd and BS Wilson (1983) Specific endocrine tissue marker defined by a monoclonal antibody. Science 222 628-630.
26. DT O'Connor, D Burton and LJ Deftos (1983) Chromogranin A: Immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine glands. Life Sci 33 1657-1663.
27. BS Wilson and RV Lloyd (1984) Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 115 458-468.
28. C Hagn, KW Schmid, R Fischer-Colbrie, et al. (1986) Chromogranin A, B, and C in human adrenal medulla and endocrine tissues. Lab Invest 55 405-411.
29. WB Huttner, H-H Gerdes and P Rosa (1991) Chromogranins/secretogranins – widespread constituents of the secretory granule matrix in endocrine cells and neurons. K Langley, M Gratzl (Eds) Markers for neural and endocrine cells: molecular and cell biology Weinhein, VCH
30. MG Portela-Gomes, GW Hacker and R Weitgasser (2004) Neuroendocrine cell markers for pancreatic islets and tumors. Appl Immunohistochem Mol Morphol 12 183-192.
31. AG Fahrenkamp, C Wibbeke and G Winde (1995) Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumors of the gastrointestinal tract. Virchows Arch 426 361-367.
32. KW Schmid, M Kroll, A Hittmair, et al. (1991) Chromogranin A and B in adenomas of the pituitary: An immunohistochemical study of 42 cases. Am J Surg Pathol 15 1072-1077.
33. R Buffa, M Pelagi, AG Siccardi, et al. (1990) Identification of the endocrine cells detected by the monoclonal antibody HISL-19 in human tissues. Basic Appl Histochem 34 259-268.
34. K Riddel, D Tippens and AM Gown (1987) PHE5: A new monoclonal antibody to a unique neuroendocrine granule protein. Lab Invest 56 64A.
35. K Krisch, G Horvat, I Krisch, et al. (1988) Immunochemical characterization of a novel secretory protein (defined by monoclonal antibody HISL-19) of peptide hormone producing cells which is distinct from chromogranin A, B and C. Lab Invest 58 411-420.
36. VE Gould, I Lee, B Wiedenmann, et al. (1986) Synaptophysin: A novel marker for neurons, certain neuroendocrine cells and their neoplasms. Hum Pathol 17 979-983.
37. P Komminoth, J Roth, S Schroder, et al. (1995) Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas: Implications for the differential diagnosis of adrenal gland tumors. Lab Invest 72 424-431.
38. GM Portela-Gomes, GM Lukinius and L Grimelius (2000) Synaptic vesicle protein 2: A new neuroendocrine cell marker. Am J Pathol 157 1299-1309.
39. AM Jakobsen, P Anderson, G Saglik, et al. (2001) Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumors. J Pathol 195 463-472.
40. A Gut, CE Kiraly, M Fukuda, et al. (2001) Expression and localization of synaptotagmin isoforms in endocrine beta cells: their function in insulin exocytosos. J Cell Sci 114 1709-1716.
41. B Adolfsen, S Saraswati, M Yoshihara, et al. (2004) Synaptotagmins are trafficked to distinct subcellular domains including the postsynaptic compartment. J Cell Bol 166 249-260.
42. R Regazzi, CB Wolheim, J Lang, et al. (1995) VAMP-2 and cellubrevin are expressed in pancreatic beta cells and are essential for Ca(2+) but not for GTP gamma S-induced insulin secretion. EMBO J 14 2723-2730.
43. B Wiedenmann, M John, G Ahnert-Hilger and E-O Riecken (1998) Molecular and cell biological aspects of neuroendocrine tumors of the gastrointestinal tract. J Mol Med 76 637-647.
44. DA Arber and LM Weirs (1995) CD57: A review. Appl Immunohistochem 3 137-152.
45. RC McGarry, SL Helfand, RH Quarles, et al. (1983) Recognition of the myelin associated glycoprotein by the monoclonal antibody HNK-1. Nature 306 376-378.
46. AS Tischler, H Mobtaker, K Mann, et al. (1986) Anti-lymphocyte antibody Leu 7 (HNK-1) recognizes a constituent of neuroendocrine granule matrix. J Histochem Cytochem 34 1213-1216.
47. VS Ghali, EJS Jimenez and RL Garcia (1992) Distribution of Leu 7 antigen (HNK-1) in thyroid tumors: Its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum Pathol 23 21-25.
48. K Langley and M Gratzl (1991) Neural cell adhesion molecule (NCAM) in neural and endocrine cells. K Langley, M Gratzl (Eds) Markers for neural and endocrine cells: molecular and cell biology. diagnostic applications Weinheim VCH 133-177.
49. WR Shipley, RD Hammer, WJ Lennington, et al. (1997) Paraffin immunohistochemical detection of CD56, a useful marker for neural cell adhesion molecule in normal and neoplastic fixed tissues. Appl Immunohistochem 5 87-93.
50. L Jin, JJ Hemperly and RV Lloyd (1991) Expression of neural cell adhesion molecule in normal and neoplastic human neuroendocrine tissues. Am J Pathol 138 961-969.
51. P Komminoth, J Roth, P Saremaslani, et al. (1994) Polysialic acid of the neural cell adhesion molecule in the human thyroid: A marker for medullary thyroid carcinoma and primary C-cell hyperplasia: An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 18 399-411.
52. P Komminoth, J Roth, PM Lackie, et al. (1991) Polysialic acid of the neural cell adhesion molecule distinguishes small cell lung carcinoma from carcinoids. Am J Pathol 139 297-304.
53. E Fuchs and K Weber (1994) Intermediate filaments: Structure, dynamics, function and disease. Ann Rev Biochem 63 345-382.
54. H Hoefler, H Denk, E Lackinger, et al. (1986) Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumors. Virchows Arch A Pathol Anat Histopathol 409 609-626.
55. BJ O'Hara, A Paetau and M Miettinen (1998) Keratin subsets and monoclonal antibody to HBME-1 in chordoma: Immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol 29 119-126.
56. NP Wang, S Zee, RJ Zarbo, et al. (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3 99-107.
57. JQ Trojanowski, VM Lee and WW Schlaepfer (1984) An immunohistochemical study of human central and peripheral nervous system tumors, using monoclonal antibodies against neurofilaments and glial filaments. Hum Pathol 15 248-257.
58. MA Perez, SH Saul and JQ Trojanowski (1990) Neurofilament and chromogranin expression in normal and neoplastic neuroendocrine cells of the human gastrointestinal tract and pancreas. Cancer 65 1219-1227.
59. E Kulig and RV Lloyd (1996) Transcription factors and endocrine disease. Endocr Pathol 1 245-250.
60. JC Reubi, A Kappeler, B Waser, et al. (1998) Immunohistochemical localization of somatostatin receptors sst2A in human tumors. Am J Pathol 153 233-245.
61. LA Erickson, L Jin, P Wollen, et al. (1999) Parathyroid hyperplasia, adenomas and carcinomas: differential expression of p27 Kip1 protein. AM J Surg Pathol 23 288-295.
62. S LaRosa, F Sessa, C Capella, et al. (1996) Prognostic criteria in non-functioning pancreatic endocrine tumors. Virchows Arc 429 323-333.
63. RA DeLellis (1997) Proliferation markers in neuroendocrine tumors: useful or useless? A critical reappraisal. Verh Dtsch Ges Pathol 81 53-61.
64. SL Asa (1998) Atlas of tumor pathology: tumors of the pituitary gland Washington, DC: Armed Forces Institute of Pathology
65. C Girod, J Trouillar and MP Dubois (1985) Immunocytochemical localization of S100 protein in stellate cells (folliculostellate cells) of the anterior lobe of the normal human pituitary. Cell Tissue Res 241 505-511.
66. RV Lloyd, M Cano, P Rosa, et al. (1988) Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Am J Pathol 130 296-304.
67. LA Erickson and RV Lloyd (2004) Practical markers used in the diagnosis of endocrine tumors. Adv Anat Pathol 11 175-189.
68. H Hofler, GF Walter and H Denk (1994) Immunohistochemistry of folliculostellate cells in normal human adenohypophyses and in pituitary adenomas. Acta Neuropathol (Berl) 65 35-40.
69. RA DeLellis, RV Lloyd, P Heitz, et al. (2004) Tumours of the endocrine organs. WHO Classification of Tumours
70. K Thappar, K Kovacs, BW Scheithauer, et al. (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurg 38 99-106.
71. K Thappar, BW Schaithauer, K Kovacs, et al. (1996) p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurg 38 765-771.
72. PC Burger and BW Scheithauer (1994) Atlas of tumor pathology: tumors of the central nervous system. Third Series Washington, DC: Armed Forces Institute of Pathology
73. S Coca, J Vaquero, J Escandon, et al. (1992) Immunohistochemical characterization of pineocytomas. Clin Neuropathol 11 298-303.
74. K Hayashi, Y Hoshida, Y Horie, et al. (1991) Immunohistochemical study on the distribution of α and β subunits of S100 protein in brain tumors. Acta Neuropathol (Berl) 81 657-663.
75. HW Korf, DC Klein, JS Zigler, et al. (1986) S-antigen-like immunoreactivity in a human pineocytoma. Acta Neuropathol (Berl) 69 165-167.
76. E Perentes, LJ Rubinstein, MM Herman, et al. (1986) S-antigen immunoreactivity in human pineal glands and pineal parenchymal tumors: A monoclonal antibody study. Acta Neuropathol (Berl) 71 224-227.
77. W Bocker, H Dralle and G Dorn (1981) Thyroglobulin: An immunohistochemical marker in thyroid disease. RA DeLellis (Eds) Diagnostic immunohistochemistry New York: Masson 37-60.
78. C Sambade, K Franssila, J Cameselle-Teijeiro, et al. (1991) Hyalinizing trabecular adenoma: A misnomer for a peculiar tumor of the thyroid gland. Endocr Pathol 2 83-91.
79. M Hirokawa and JA Carney (2000) Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid. Am J Surg Pathol 24 575-578.
80. JL Berge-Lefranc, G Cartouzou, C DeMicco, et al. (1985) Quantification of thyroglobulin messenger RNA by in-situ hybridization in differentiated thyroid cancers: Difference between welldifferentiated and moderately differentiated histologic types. Cancer 56 345-350.
81. CE Keen, S Szakacs, E Okon, et al. (1999) CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not entirely specific for site of origin. Histopathology 34 113-117.
82. ML Carcangiu, G Zampi and J Rosai (1984) Poorly differentiated (‘insular’) thyroid carcinoma: A reinterpretation of Langhans' ‘wuchernde Struma.’. Am J Surg Pathol 8 655-668.
83. NG Ordonez, AK El-Naggar, RC Hickey, et al. (1991) Anaplastic thyroid carcinoma: Immunocytochemical study of 32 cases. Am J Clin Pathol 96 15-24.
84. ML Carcangiu, T Steeper, G Zampi, et al. (1985) Anaplastic thyroid cancer: A study of 70 cases. Am J Clin Pathol 83 135-158.
85. A Kawaoi, T Okano, N Nemoto, et al. (1982) Simultaneous detection of thyroglobulin (Tg), thyroxine (T4) and triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method. Am J Pathol 108 39-49.
86. SK Lau, DJ Luthringer and RN Eisen (2002) Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol 10 97-102.
87. NG Ordonez (2000) Thyroid transcription factor 1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 7 123-127.
88. O Kaufmann and M Dietel (2000) Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 36 8-16.
89. AL Byrd-Gloster, A Khoor, LF Glass, et al. (2000) Differential expression of thyroid transcription factor-1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 31 58-62.
90. SN Agoff, LW Lamps, AT Philip, et al. (2000) Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 13 238-242.
91. SC Henzen-Logmans, H Mullink, FC Ramaekers, et al. (1987) Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue. Virchows Arch A Pathol Anat Histopathol 410 347-354.
92. M Miettinen, K Franssila, V-P Lehto, et al. (1984) Expression of intermediate filament proteins in thyroid gland and thyroid tumors. Lab Invest 50 262-270.
93. G Viale, P Dell'Orto, G Coggi, et al. (1989) Co-expression of cytokeratins and vimentin in normal and diseased thyroid glands: Lack of diagnostic utility of vimentin immunostaining. Am J Surg Pathol 13 1034-1040.
94. LJDM Schelfhout, GN van Muijen and GJ Fleuren (1989) Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma. Am J Clin Pathol 92 654-658.
95. SJ Raphael, G McKeown-Eyssen and SL Asa (1994) High molecular weight cytokeratin and cytokeratin 19 in the diagnosis of thyroid tumors. Mod Pathol 7 295-300.
96. E Fonseca, JM Nesland, J Hoie, et al. (1997) Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: An immunohistochemical study of simple and stratified epithelial-type cytokeratins. Virchows Arch 430 239-245.
97. M Miettinen, AJ Kovatich and P Karkkainen (1997) Keratin subsets in papillary and follicular thyroid lesions: A paraffin section analysis with diagnostic implications. Virchows Arch 431 407-413.
98. ZW Baloch, S Abraham, S Roberts, et al. (1999) Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility. Hum Pathol 30 1166-1171.
99. B Kragsterman, L Grimelius, G Wallin, et al. (1999) Cytokeratin 19 expression in papillary thyroid carcinoma. Appl Immunohistochem 7 181-185.
100. E Fonseca, J Nesland and M Sobrinho-Simoes (1997) Expression of stratified epithelial cytokeratins in hyalinizing trabecular adenoma supports their relationship with papillary carcinoma of the thyroid. Histopathology 31 330-335.
101. M Hirokawa, JA Carney and Y Ohtsuki (2000) Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid express different cytokeratin patterns. Am J Surg Pathol 24 877-881.
102. E Liberman and N Weidner (2000) Papillary and follicular neoplasms of the thyroid gland: Differential immunohistochemical staining with high molecular weight keratin and involucrin. Appl Immunohistochem 8 42-48.
103. MJ Sack, C Astengo-Osuna, BT Lin, et al. (1997) HBME-1 immunostaining in thyroid fine needle aspirations: A useful marker in the diagnosis of carcinoma. Mod Pathol 10 668-674.
104. M Miettinen and P Karkkainen (1996) Differential HBME-1 reactivity in benign vs. malignant thyroid tissue is helpful in the diagnosis of thyroid tumors [abstract]. Mod Pathol 5 50A.
105. T Mase, H Funahashi, T Koshikawa, et al. (2003) HBME-1 immunostaining in thyroid tumors, especially in follicular neoplasms. Endocr J 50 173-177.
106. MB Casey, CM Lohse and RV Lloyd (2003) Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3 and HBME-1. Endocr Pathol 14 55-60.
107. XC Xu, AK el-Nagger and R Lotan (1995) Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147 815-822.
108. PL Fernandez, MJ Merino, M Gomez, et al. (1997) Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J. Pathol 181 80-86.
109. F Orlandi, E Saggiorato, G Pivano, et al. (1998) Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 58 3015-3020.
110. ME Herrmann, VA LiVolsi, TL Pasha, et al. (2002) Immunohistochemical expression of galectin 3 in benign and malignant lesions. Arch Pathol Lab Med 126 710-713.
111. A Bartolazzi, A Gasbarri, M Papotti, et al. (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357 1644-1650.
112. M Volante, F Bozzalla-Cassione, R DePompa, et al. (2004) Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. Virchows Arch 445 183-188.
113. M Dasovic-Knezevic, O Bormer, R Holm, et al. (1989) Carcinoembryonic antigen in medullary thyroid carcinoma: An immunohistochemical study applying six novel monoclonal antibodies. Mod Pathol 2 610-617.
114. S Schroder, W Schwarz, W Rehpenning, et al. (1987) Prognostic significance of Leu M1 immunostaining in papillary carcinomas of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 411 435-439.
115. TS Loy, GV Darkow, LE Spollen, et al. (1994) Immunostaining for Leu 7 in the diagnosis of thyroid carcinoma. Arch Pathol Lab Med 118 172-174.
116. ML Ostrowski, RW Brown, TM Wheeler, et al. (1995) Leu 7 immunoreactivity in cytologic specimens of thyroid lesions with an emphasis on follicular neoplasms. Diagn Cytopathol 12 297-302.
117. Z Gatalica and M Miettinen (1994) Distribution of carcinoma antigens CA19-9 and CA15-3: An immunohistochemical study of 400 tumors. Appl Immunohistochem 2 205-211.
118. P Alves, P Soares, E Fonseca, et al. (1999) Papillary thyroid carcinoma overexpresses fully and underglycosylated mucins together with native and sialylated simple mucin antigens and histo-blood group antigens. Endocrine Pathol 10 315-324.
119. P Soares, J Cameselle-Teijeiro and M Sobrinho-Simoes (1994) Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 24 205-210.
120. R Holm and JM Nesland (1994) Retinoblastoma and p53 tumor suppressor gene protein expression in carcinomas of the thyroid gland. J Pathol 172 267-272.
121. G Tallini, M Santoro, M Helie, et al. (1998) RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4 287-294.
122. M Papotti, M Volante, A Guiliano, et al. (2000) RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 24 1615-1621.
123. CC Cheung, SL Boerner, CM MacMillan, et al. (2000) Hyalinizing trabecular tumor of the thyroid: A variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 24 1622-1626.
124. VA LiVolsi (2000) Hyalinizing trabecular tumor of the thyroid: Adenoma, carcinoma, or neoplasm of uncertain malignant potential? Am J Surg Pathol 24 1683-1684.
125. TG Kroll, P Sarraf, L Pecciarini, et al. (2000) PAX8-PPAR gamma 1 fusion oncogene in human thyroid carcinoma. Science 289 1357-1360.
126. MN Nikiforova, PW Biddinger, CM Candill, et al. (2002) PAX8-PPAR gamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyser. Am J Surg Pathol 26 1016-1023.
127. AR Marques, C Espadinha, AL Catarino, et al. (2002) Expression of PAX8-PPAR gamma rearrangements in both follicular thyroid carcinoma and adenoma. J Clin Endocrinol Metab 87 3947-3952.
128. L Cheung, M Messina, A Gill, et al. (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 88 354-357.
129. M Bur, W Shiraki and S Masood (1993) Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissue. Mod Pathol 6 469-472.
130. KM McLaren and DW Cossar (1996) The immunohistochemical localization of S-100 in the diagnosis of papillary carcinoma of the thyroid. Hum Pathol 27 633-636.
131. M Papotti, P Gugliotta, G Forte, et al. (1994) Immunocytochemical identification of oxyphilic mitochondrion rich cells. Appl Immunohistochem 2 261-267.
132. K Nylander, B Vojtesek, R Nenutil, et al. (2002) Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 198 417-427.
133. JL Hunt, VA LiVolsi and EL Barnes (2004) p63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid. Mod Pathol 17 526-529.
134. RA DeLellis and HJ Wolfe (1981) The pathology of the human calcitonin C- cell. Pathol Annu 16 25-52.
135. KL Sikri, IM Varndell, QA Hamid, et al. (1985) Medullary carcinoma of the thyroid: An immunocytochemical and histochemical study of 25 cases using 8 separate markers. Cancer 56 2481-2491.
136. A Perry, K Molberg and J Albores-Saavedra (1996) Physiologic versus neoplastic C-cell hyperplasia of the thyroid: Separation of distinct histologic and biologic entities. Cancer 77 750-756.
137. R Holm, M Sobrinho-Simoes, JM Nesland, et al. (1985) Medullary carcinoma of the thyroid gland: An immunocytochemical study. Ultrastruct Pathol 8 25-41.
138. M Uribe, CM Fenoglio-Preiser, M Grimes, et al. (1985) Medullary carcinoma of the thyroid gland: Clinical, pathological and immunohistochemical features with a review of the literature. Am J Surg Pathol 9 577-594.
139. JD Zajac, J Penschow, T Mason, et al. (1986) Identification of calcitonin and calcitonin gene related peptide messenger RNA in medullary thyroid carcinoma by hybridization histochemistry. J Clin Endocrinol Metab 62 1037-1043.
140. V Eusebi, S Damiani, C Riva, et al. (1990) Calcitonin-free oat cell carcinoma of the thyroid gland. Virchows Arch A Pathol Anat Histopathol 417 267-271.
141. B Franc, M Rosenberg-Bourgin, B Caillou, et al. (1998) Medullary thyroid carcinoma: Search for histological predictors of survival (109 proband case analysis). Hum Pathol 29 1078-1084.
142. PH Steenbergh, JW Hoppener, J Zandberg, et al. (1984) Calcitonin gene related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid carcinoma. J Clin Endocrinol Metab 59 358-360.
143. P Komminoth, J Roth, P Saremaslani, et al. (1994) Polysialic acid of the neural cell adhesion molecule in the human thyroid: A marker for medullary thyroid carcinoma and primary C-cell hyperplasia: An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 18 399-411.
144. L Scopsi, C Ferrari, S Pilotti, et al. (1990) Immunocytochemical localization and identification of prosomatostatin gene products in medullary carcinoma of human thyroid gland. Hum Pathol 21 820-830.
145. ME Sunday, HJ Wolfe, BA Roos, et al. (1988) Gastrin releasing peptide gene expression in developing, hyperplastic and neoplastic thyroid C-cells. Endocrinology 122 1551-1558.
146. PU Heitz, G von Herbay, G Kloppel, et al. (1987) The expression of subunits of human chorionic gonadotropin (hCG) by nontrophoblastic, nonendocrine and endocrine tumors. Am J Clin Pathol 88 467-472.
147. RA DeLellis, FM Moore and HJ Wolfe (1983) Thyroglobulin immunoreactivity in human medullary thyroid carcinoma. Lab Invest 48 20A.
148. R Holm, M Sobrinho-Simoes, JM Nesland, et al. (1986) Concurrent production of calcitonin and thyroglobulin by the same neoplastic cells. Ultrastruct Pathol 10 241-248.
149. O Ljungberg, L Bondeson and AG Bondeson (1984) Differentiated thyroid carcinoma, intermediate type: A new tumor entity with features of follicular and parafollicular cell carcinomas. Hum Pathol 15 218-228.
150. M Volante, M Papotti, J Roth, et al. (1999) Mixed medullary follicular thyroid carcinoma: Molecular evidence for a dual origin of tumor components. Am J Pathol 155 1499-1509.
151. KW Schmid, R Fischer-Colbrie, C Hagn, et al. (1987) Chromogranin A and B and secretogranin II in medullary carcinomas of the thyroid. Am J Surg Pathol 11 551-556.
152. CD Katsetos, MM Jami, L Krishna, et al. (1994) Novel immunohistochemical localization of 28000 molecular weight (Mr) calcium binding protein (Calbindin-D28k) in enterochromaffin cells of the human appendix and neuroendocrine tumors (carcinoids and small cell carcinomas) of the midgut and foregut. Arch Pathol Lab Med 118 633-639.
153. G Viale, M Roncalli, L Grimelius, et al. (1995) Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 26 945-950.
154. RA DeLellis, AH Rule, I Spiler, et al. (1978) Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 70 587-594.
155. S Schroder and G Kloppel (1987) Carcinoembryonic antigen and nonspecific cross-reacting antigen in thyroid cancer: An immunocytochemical study using polyclonal and monoclonal antibodies. Am J Surg Pathol 11 100-108.
156. G Mendelsohn, SA Wills Jr and SB Baylin (1984) Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma: An immunohistochemical study in early, localized and virulent disseminated stages of disease. Cancer 54 657-662.
157. N Kimura, Y Nakazato, H Nagura, et al. (1990) Expression of intermediate filaments in neuroendocrine tumors. Arch Pathol Lab Med 114 506-510.
158. M Miettinen, R Clark, VP Lehto, et al. (1985) Intermediate filament proteins in parathyroid glands and parathyroid adenomas. Arch Pathol Lab Med 109 986-989.
159. JM Futrell, SI Roth, SP Su, et al. (1979) Immunocytochemical localization of parathyroid hormone in bovine parathyroid glands and human parathyroid adenomas. Am J Pathol 94 615-622.
160. T Tomita (1999) Immunocytochemical staining patterns for parathyroid hormone and chromogranin in parathyroid hyperplasia, adenoma and carcinoma. Endocr Pathol 10 145-156.
161. PJ Stork, C Herteaux, R Frazier, et al. (1992) Expression and distribution of parathyroid hormone and parathyroid hormone messenger RNA in pathological conditions of the parathyroid gland. Lab Invest 61 169-174.
162. CJ Weber, J Russell, JT Chryssochoos, et al. (1996) Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperpara-thyroidism. World J Surg 20 1010-1015.
163. JA Danks, PR Ebeling, J Hayman, et al. (1989) Parathyroid hormone related protein: Immunohistochemical localization in cancers and in normal skin. J Bone Miner Res 4 273-278.
164. KW Schmid, JM Morgan, M Baumert, et al. (1995) Calcitonin and calcitonin gene related peptide mRNA detection in a population of hyperplastic parathyroid cells, also expressing chromogranin B. Lab Invest 73 90-95.
165. A Kahn, AS Tischler, NA Patwardhan, et al. (2003) Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands. Endocr Pathol 14 249-250.
166. P Hellman, A Karlsson-Parra, L Klareskog, et al. (1996) Expression and function of a CD4-like molecule in parathyroid tissue. Surgery 120 985-992.
167. MA Vasef, RK Brynes, M Sturm, et al. (1999) Expression of cyclin D1 in parathyroid carcinomas, adenomas and hyperplasias: A paraffin immunohistochemical study. Mod Pathol 12 412-416.
168. GC Abbona, M Papotti, G Gasparri, et al. (1995) Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26 135-138.
169. MP Vargas, HI Vargas, DE Kleiner, et al. (1997) The role of prognostic markers (MIB-1, RB, bcl-2) in the diagnosis of parathyroid tumors. Mod Pathol 10 12-17.
170. VL Cryns, A Thor, H-J Xu, et al. (1994) Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N Engl J Med 330 757-761.
171. F Farnebo, G Auer, LO Farnebo, et al. (1999) Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease. World J Surg 23 68-74.
172. MJ Kayath, LC Martin, JG Vieira, et al. (1998) A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas. Eur J Endocrinol 139 78-83.
173. S Schroder, A Niendorf, E Achilles, et al. (1990) Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11. Virchows Arch A Pathol Anat Histopathol 417 89-96.
174. S Schroder, BC Padberg, E Achilles, et al. (1992) Immunocytochemistry in adrenocortical tumors: A clinicopathological study of 72 neoplasms. Virchows Arch A Pathol Anat Histopathol 420 65-70.
175. E Tartour, B Caillou, F Tenenbaum, et al. (1993) Immunohistochemical study of adrenocortical carcinoma: Predictive value of the D11 monoclonal antibody. Cancer 72 3296-3303.
176. H Sasano, S Shizawa, T Suzuki, et al. (1995) Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy. Hum Pathol 26 1154-1156.
177. KJ Busam, K Iversen, KA Coplan, et al. (1998) Immunoreactivity for A103, an antibody to melan-A (Mart-1) in adrenocortical and other steroid tumors. Am J Surg Pathol 22 57-63.
178. AA Renshaw and SR Granter (1998) A comparison of A103 and inhibin reactivity in adrenal cortical tumors: Distinction from hepatocellular carcinoma and renal tumors. Mod Pathol 11 1160-1164.
179. TS Loy, RW Phillips and CL Linder (2002) A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases. Arch Pathol Lab Med 126 170-172.
180. Z Ghorab, M Jorda, P Ganjei, et al. (2003) Melan-A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas. Appl Immunohistochem Mol Morphol 11 330-333.
181. SJ Shin, RS Hoda, L Ying, et al. (2000) Diagnostic utility of the monoclonal antibody A103 in fine-needle aspiration biopsies of the adrenal. Am J Clin Pathol 113 295-302.
182. TJ Pelkey, HF Frierson, SE Mills, et al. (1998) The α submit of inhibin in adrenal cortical neoplasia. Mod Pathol 11 516-524.
183. PA Fetsch, CN Powers, M Zakowski, et al. (1999) Anti-alpha inhibin: Marker of choice for the consistent distinction between adrenocortical carcinoma (ACC) and renal cell carcinoma (RCC) in fine needle aspirations (FNA). Cancer 87 168-172.
184. WG McCluggage, P Maxwell, A Patterson, et al. (1997) Immunohistochemical staining of hepatocellular carcinoma with monoclonal antibody against inhibin. Histopathology 30 518-522.
185. LM Munro, A Kennedy and AM McNicol (1999) The expression of inhibin/activin subunits in the human adrenal cortex and its tumors. J Endocrinol 161 341-347.
186. WG McCluggage and P Maxwell (1999) Adenocarcinoma of various sites may exhibit immunoreactivity with anti-inhibin antibodies. Histopathology 35 216-220.
187. FM Brown, TA Gaffey, LE Wold, et al. (2000) Myxoid neoplasms of the adrenal cortex: a rare histologic variant. Am J Surg Pathol 24 396-410.
188. J Arola, J Liu, P Heikkila, et al. (2000) Expression of inhibin alpha in adrenocortical tumors reflects the hormonal status of the neoplasm. J Endocrinol 165 223-229.
189. EY Cho and GH Ahn (2001) Immunoexpression of inhibin α-subunit in adrenal neoplasms. Appl Immunohistochem Mol Morphol 9 222-228.
190. M Miettinen (1992) Neuroendocrine differentiation in adrenocortical carcinoma: New immunohistochemical findings supported by electron microscopy. Lab Invest 66 169-174.
191. R Chetty, P Pillay and V Jaichand (1998) Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas. J Clin Pathol 51 477-478.
192. N Kimura, Y Nakazato, H Nagura, et al. (1990) Expression of intermediate filaments in neuroendocrine tumors. Arch Pathol Lab Med 114 506-510.
193. F Fogt, AO Vortmeyer, C Poremba, et al. (1998) Bcl-2 expression in normal adrenal glands and in adrenal neoplasms. Mod Pathol 11 716-720.
194. PJ Zhang, EM Genega, JE Tomaszewski, et al. (2003) The role of calretinin, inhibin, melan-A, bcl-2, and c-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod Pathol 16 591-597.
195. M Jorda, B De Madeiros and M Nadji (2002) Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas. Appl Immunohistochem Mol Morphol 10 67-70.
196. M Miettinen, V-P Lehto and I Virtanen (1985) Immunofluorescence microscopic evaluation of the intermediate filament expression of the adrenal cortex and medulla and their tumors. Am J Pathol 118 360-366.
197. MJ Gaffey, ST Traweek, SE Mills, et al. (1992) Cytokeratin expression in adrenocortical neoplasia: An immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular and renal cell carcinoma. Hum Pathol 23 144-153.
198. MR Wick, DL Cherwitz, RC McGlennen, et al. (1986) Adrenocortical carcinoma: An immunohistochemical comparison with renal cell carcinoma. Am J Pathol 122 343-352.
199. RJ Cote, C Cardon-Cardo, VE Reuter, et al. (1990) Immunopathology of adrenal and renal cortical tumors: Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Am J Pathol 136 1077-1084.
200. PD Unger, K Hoffman, SN Thung, et al. (1992) HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med 116 151-153.
201. JG Caya (1994) HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med 118 1169.
202. RV Lloyd, B Shapiro, JC Sisson, et al. (1984) An immunohistochemical study of pheochromocytomas. Arch Pathol Lab Med 108 541-544.
203. RV Lloyd, M Blaivas and BS Wilson (1985) Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues. Arch Pathol Lab Med 109 633-635.
204. AAJ Verhofstad, HWM Steinbusch, JWJ Joosten, et al. (1983) Immunocytochemical localization of nonadrenaline, adrenaline and serotonin. JM Polak, S Van Noordens (Eds) Immunohistochemistry: practical applications in pathology and biology Bristol, England: Wright-PSG 143-168.
205. JQ Trojanowski and VM Lee (1985) Expression of neurofilament antigens by normal and neoplastic human adrenal chromaffin cells. N Engl J Med 313 101-104.
206. DJ Grignon, JY Ro, B Mackay, et al. (1991) Paraganglioma of the urinary bladder: Immunohistochemical, ultrastructural and DNA flow cytometric studies. Hum Pathol 22 1162-1169.
207. TL Johnson, RJ Zarbo, RV Lloyd, et al. (1988) Paragangliomas of the head and neck: Immunohistochemical neuroendocrine and intermediate filament typing. Mod Pathol 1 216-223.
208. SA Salim, C Milroy, J Rode, et al. (1993) Immunocytochemical characterization of neuroendocrine tumors of the larynx. Histopathology 23 69-73.
209. LJ Helman, PS Cohen, SD Averbuch, et al. (1989) Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma. J Clin Oncol 7 720-725.
210. MR Clarke, RJ Weyant, CG Watson, et al. (1998) Prognostic markers in pheochromocytoma. Hum Pathol 29 522-526.
211. C August, K August, S Schroeder, et al. (2004) CGH and CD44/MIB-1 immunohistochemistry are helpful to distinguish metastasized sporadic pheochromocytomas. Mod Pathol 17 1119-1128.
212. TJ Triche and F Askin (1983) Neuroblastoma and the differential diagnosis of small, round, blue cell tumors. Hum Pathol 14 569-595.
213. Y Hachitanda, M Tsuneyoshi and M Enjoji (1989) An ultrastructural and immunohistochemical evaluation of cytodifferentiation in neuroblastic tumors. Mod Pathol 2 13-19.
214. A Pagani, M Forni, GP Tonini, et al. (1992) Expression of members of the chromogranin family in primary neuroblastomas. Diagn Mol Pathol 1 16-24.
215. RL Carter, SZ Al-sams, RP Corbett, et al. (1990) A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 in neuroblastoma, Ewing's sarcoma and other round cell tumors in children. Histopathology 16 461-467.
216. GH Wirnsberger, H Becker, K Ziervogel, et al. (1992) Diagnostic immunohistochemistry of neuroblastic tumors. Am J Surg Pathol 16 49-57.
217. DW Franquemont, SE Mills and EE Lack (1994) Immunohistochemical detection of neuroblastomatous foci in composite adrenal pheochromocytoma-neuroblastoma. Am J Clin Pathol 102 163-170.
218. P Argani, RA Erlandson and J Rosai (1997) Thymic neuroblastoma in adults: Report of three cases with special emphasis on its association with the syndrome of inappropriate secretion of antidiuretic hormone. Am J Clin Pathol 108 537-543.
219. EJ Fellinger, P Garin-Chesa, TJ Triche, et al. (1991) Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32 MIC2. Am J Pathol 39 317-325.
220. AJ Stevenson, J Chatten, F Bertoni, et al. (1994) CD99 (p30/32MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: Review of more than 600 tumors and the literature experience. Appl Immunohistochem 2 231-240.
221. N Weidner and J Tjoe (1994) Immunohistochemical profile of monoclonal antibody 013: Antibody that recognizes glycoprotein p 30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 18 486-494.
222. K Scotlandi, M Serra, MC Manara, et al. (1996) Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. Hum Pathol 27 408-416.
223. E Hess, C Cohen, PB DeRose, et al. (1997) Nonspecificity of p30/32MIC2 immunolocalization with the 013 monoclonal antibody in the diagnosis of Ewing's sarcoma: Application of an algorithmic immunohistochemical analysis. Appl Immunohistochem 5 94-103.
224. AS Pappo, ED Douglass, WH Meyer, et al. (1993) Use of HBA 71 and anti-B2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. Hum Pathol 24 880-885.
225. M Miettinen, J Chatten, A Paetau, et al. (1998) Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am J Surg Pathol 22 327-332.
226. AL Folpe, K Patterson and AM Gown (1997) Antineuroblastoma antibody NB-84 also identifies a significant subset of other small blue round cell tumors. Appl Immunohistochem 5 239-245.
227. Y Dayal (1991) Endocrine cells of the gut and their neoplasms. HT Norris (Eds) Pathology of the colon, small intestine and anus New York: Churchill Livingstone 305-366.
228. R Moll and WW Franke (1985) Cytoskeletal differences between human neuroendocrine tumors: A cytoskeletal protein of molecular weight 46000 distinguishes cutaneous from pulmonary neuroendocrine tumors. Differentiation 30 165-175.
229. AP Burke, LH Sobin, BH Federspiel, et al. (1989) Appendiceal carcinoids: Correlation of histology and immunohistochemistry. Mod Pathol 2 630-637.
230. M Miettinen (1995) Keratin 20: Immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8 384-388.
231. B Al-Khafaji, AE Noffsinger, MA Miller, et al. (1998) Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors. Hum Pathol 29 992-999.
232. N Kimura, M Pilichowska, H Okamoto, et al. (2000) Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod Pathol 13 140-146.
233. RM Thomas, JH Baybick, AM Elsayed, et al. (1994) Gastric carcinoids: An immunohistochemical and clinicopathologic study of 104 patients. Cancer 73 2053-2058.
234. HR Machlouf, AP Burke and LH Sobin (1999) Carcinoid tumors of the ampulla of Vater: A comparison with duodenal carcinoid tumors. Cancer 85 1241-1249.
235. K Sheibani, H Battifora, JS Burke, et al. (1986) Leu-M1 antigen in human neoplasms: An immunohistologic study of 400 cases. Am J Surg Pathol 10 227-236.
236. CA Moskaluk, H Zheng, SM Powell, et al. (2003) CDX2 protein expression in normal and malignant human tissue: an immunohistochemical survey using tissue microarrrays. Mod Pathol 16 913-919.
237. N Azumi, ST Traweek and H Battifora (1991) Prostatic acid phosphatase in carcinoid tumors: Immunohistochemical and immunoblot studies. Am J Surg Pathol 15 785-790.
238. IA Shah, M-O Schlageter and D Netto (1991) Immunoreactivity of neurofilament proteins in neuroendocrine neoplasms. Mod Pathol 4 215-219.
239. G Chejfec, S Falkmer, L Grimelius, et al. (1987) Synaptophysin: A new marker for pancreatic neuroendocrine tumors. Am J Surg Pathol 11 241-247.
240. E Solcia, C Capella and G Kloppel (1997) Atlas of tumor pathology: tumors of the pancreas Washington, DC: Armed Forces Institute of Pathology
241. PU Heitz, M Kasper, JM Polak, et al. (1982) Pancreatic endocrine tumors: Immunocytochemical analysis of 125 tumors. Hum Pathol 13 263-271.
242. PL Perkins, MK McLeod, L Jin, et al. (1992) Analysis of gastrinomas by immunohistochemistry and in-situ hybridization histochemistry. Diagn Mol Pathol 1 155-164.
243. M-F Le Bodic, M-F Heyman, M Lecomete, et al. (1996) Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia type I. Am J Surg Pathol 20 1378-1384.
244. E Solcia, C Capella, C Riva, et al. (1988) The morphology and neuroendocrine profile of pancreatic epithelial VIPomas and extrapancreatic VIP producing neurogenic tumors. Ann NY Acad Sci 527 508-517.
245. PU Heitz, M Kasper, G Kloppel, et al. (1983) Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: A specific marker for malignancy: Immunocytochemical analysis of tumors of 155 patients. Cancer 51 277-282.
246. F Graeme-Cook, G Nardi and CC Compton (1990) Immunocytochemical staining for human chorionic gonadotropin subunits does not predict malignancy in insulinomas. Am J Clin Pathol 93 273-276.
247. G Viale, C Doglioni, M Gambacorta, et al. (1992) Progesterone receptor immunoreactivity in pancreatic endocrine tumors: An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts and skin. Cancer 70 2268-2277.
248. VE Gould, RI Linnoila, VA Memoli, et al. (1983) Neuroendocrine components of the bronchopulmonary tract: Hyperplasias, dysplasias and neoplasias. Lab Invest 49 519-537.
249. WD Travis, ID Linnoila, MG Tsokos, et al. (1991) Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma: An ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol 15 529-553.
250. GA Blobel, VE Gould, R Moll, et al. (1985) Co-expression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest 52 39-51.
251. AM Oliveira, HD Tazelaar, JL Myers, et al. (2001) Thyroid transcription factor-1 distinguishes metastatic pulmonary from well differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25 815-819.
252. YC Cai, B Banner, J Glickman, et al. (2001) Cytokeratin 7 and 20 and thyroid transcription factor-1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 32 1087-1093.
253. S-X Jiang, T Kameya, M Shoji, et al. (1998) Large cell neuroendocrine carcinoma of the lung: A histological and immunohistochemical study of 22 cases. Am J Surg Pathol 22 526-537.
254. DJ Gersell, G Mazoujian, DG Mutch, et al. (1988) Small cell undifferentiated carcinoma of the cervix: A clinicopathologic, ultrastructural and immunocytochemical study of 15 cases. Am J Surg Pathol 12 684-698.
255. VM Abeler, R Holm, JM Nesland, et al. (1994) Small cell carcinoma of the cervix: A clinicopathologic study of 26 patients. Cancer 73 672-677.
256. CB Gilks, RH Young, DJ Gersell, et al. (1997) Large cell neuroendocrine carcinoma of the uterine cervix: A clinicopathologic study of 12 cases. Am J Surg Pathol 21 905-914.
257. JK Chan, S Suster, B Wenig, et al. (1997) Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 21(2), 226-234.
258. SN Agoff, LW Lamps, AT Philip, et al. (2000) Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 13 238-242.
259. NG Ordonez (2000) Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 24 1217-1223.
260. JM Straughn, HE Richter, MG Conner, et al. (2001) Predictors of outcome in small cell carcinoma of the cervix – a case series. Gynecol Oncol 83 216-220.
261. N Masumoto, T Fujii, M Ishikawa, et al. (2003) p16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol 34 778-783.
262. MG Conner, H Richter, CA Moran, et al. (2002) Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases. Ann Diagn Pathol 6 345-348.
263. MH Stoler, SE Mills, DJ Gersell, et al. (1991) Small cell neuroendocrine carcinoma of the cervix: A human papillomavirus 18 associated cancer. Am J Surg Pathol 15 28-32.
264. HL Wang and DW Lu (2004) Detection of human papillomavirus DNA and expression of p16, RB, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol 28 901-908.
265. Y Sato, T Shimamoto, S Amada, et al. (2003) Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases. Int J Gynecol Pathol 22 226-230.
266. W Grayson, HA Rhemtula, LF Taylor, et al. (2002) Detection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases. J Clin Pathol 55 108-114.
267. J Matthews-Greer, H Dominguez-Malagon, GA Herrera, et al. (2004) Human papillomavirus typing of rare cervical carcinomas. Arch Pathol Lab Med 128 553-556.
268. PA diSant'Agnese, KL de Mesy Jensen, CJ Churukian, et al. (1985) Human prostatic endocrine-paracrine (APUD) cells: Distributional analysis with a comparison of serotonin and neuron specific enolase immunoreactivity and silver stains. Arch Pathol Lab Med 109 607-612.
269. PA diSant'Agnese (1998) Neuroendocrine differentiation in prostatic carcinoma: An update. Prostate (Suppl) 8 74-79.
270. KW Schmid, B Helpap, M Totsch, et al. (1994) Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate. Histopathology 24 233-239.
271. PA di Sant'Agnese (2000) Divergent neuroendocrine differentiation in prostatic carcinoma. Sem Diagn Pathol 17 149-161.
272. JE Ghannoum, RA DeLellis and SJ Shin (2004) Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: a case report. Int J Surg Pathol 12(2), 167-170.
273. N Azumi, H Shibuya and M Ishikura (1984) Primary prostatic carcinoid with intracytoplasmic prostatic acid phosphatase and prostate specific antigen. Am J Surg Pathol 8 545-550.
274. NS Goldstein (2002) Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol 117 471-477.
275. S Kawai, K Hiroshima, Y Tsukamoto, et al. (2003) Small cell carcinoma of the prostate expressing prostate-specific antigen and showing syndrome of inappropriate secretion of antidiuretic hormone: an autopsy case report. Pathol Int 53 892-896.
276. N Azumi, H Shibuya and M Ishikura (1984) Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen. Am J Surg Pathol 8 545-550.
277. NG Ordóñez (2000) Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 24(9), 1217-1223.
278. DG Bostwick, MK Dousa, BG Crawford, et al. (1994) Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Surg Pathol 18 1240-1246.
279. VE Gould, R Moll, I Moll, et al. (1985) Neuroendocrine (Merkel) cells of the skin: Hyperplasias, dysplasias and neoplasms. Lab Invest 52 334-353.
280. JKC Chan, S Suster, BM Wenig, et al. (1997) Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 21 226-234.
281. SN Leech, AJO Kolar, PD Barrett, et al. (2001) Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol 54 727-729.
282. W Cheuk, MY Kwan, S Suster, et al. (2001) Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 125 228-231.
283. AJ Hanly, GW Elgart, M Jorda, et al. (2000) Analysis of thyroid transcription factor-1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 27 118-120.
284. SA Nicholson, MB McDermott, PE Swanson, et al. (2000) CD99 and cytokeratin 20 in small cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol 8 37-41.
285. T Nagao, TA Gaffey, KD Olsen, et al. (2004) Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol 28(6), 762-770.
286. K Jensen, S Kohler and RV Rouse (2000) Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20. Appl Immunohistochem Mol Morph 8 310-315.
287. M Drijkoningen, C de Wolf-Peeters, E van Limbergen, et al. (1986) Merkel cell tumor of the skin: An immunohistochemical study. Hum Pathol 17 301-307.
288. Y Liu, J Mangini, R Saad, et al. (2003) Diagnostic value of microtubuleassociated protein-2 in Merkel cell carcinoma 11 326-329.
289. RK Sibley and D Dahl (1985) Primary neuroendocrine (Merkel cell?) carcinoma of the skin. II: An immunohistochemical study of 21 cases. Am J Surg Pathol 9 109-116.
290. C Brinkschmidt, P Stolze, AG Fahrenkamp, et al. (1995) Immunohistochemical demonstration of chromogranin A, chromogranin B and secretoneunin in Merkel cell carcinoma of the skin: An immunohistochemical study suggesting two types of Merkel cell carcinoma. Appl Immunohistochem 3 37-44.
291. DT Yang, JA Holden and SR Florell (2004) CD117, CK20, TTF-1, and DNA topoisomerase II-a antigen expression in small cell tumors. J Cutan Pathol 31 254-261.
292. LD Su, DR Fullen, L Lowe, et al. (2002) CD117 (kit receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 24 289-293.
293. S Strong, K Shalders, R Carr, et al. (2004) KIT receptor (CD117) expression in Merkel cell carcinoma. Br J Dermatol 150 384-385.
294. AC Han, AP Soler, C-K Tang, et al. (2000) Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med 124 1147-1151.
295. Y Tanaka, T Sano, ZR Qian, et al. (2004) Expression of adhesion molecules and cytokeratin 20 in Merkel cell carcinomas. Endocr Pathol 15 117-129.
296. HM Maluf and FC Koerner (1994) Carcinomas of the breast with endocrine differentiation: A review. Virchows Arch 425 449-457.
297. M Papotti, G Gherardi, V Eusebi, et al. (1992) Primary oat cell (neuroendocrine) carcinoma of the breast: Report of four cases. Virchows Arch A Pathol Anat Histopathol 420 103-108.
298. A Francois, VA Chatikhine, B Chevallier, et al. (1995) Neuroendocrine primary small cell carcinoma of the breast: Report of a case and review of the literature. Am J Clin Oncol 18 133-138.
299. SJ Shin, RA DeLellis, BA Ying, et al. (2000) Small cell carcinoma of the breast: A clinicopathological and immunohistochemical study of 9 patients. Am J Surg Pathol 24 1231-1238.
300. S Bergman, SA Hoda, KR Geisinger, et al. (2004) E-cadherin-negative primary small cell carcinoma of the breast: report of a case and review of the literature. Am J Clin Pathol 121 117-121.
301. SJ Shin, RA Detellis and PP Rosen (2001) Small cell carcinoma of the breast – Additional immunohistochemical studies. Am J Surg Pathol 25 831-832.
302. MP Hoang, A Maitra, AF Gazdar, et al. (2001) Primary mammary small cell carcinoma: a molecular analysis of 2 cases. Human Pathol 32 753-757.
303. T Yamasaki, H Shimazaki, S Aida, et al. (2000) Case report: primary small cell (oat cell) carcinoma of the breast: report of a case and review of the literature. Pathol Int 50 914-918.
304. KM Klemm and CA Moran (1999) Primary neuroendocrine carcinoma of the thymus. Semin Diagn Pathol 16 32-41.
305. CA Moran and S Suster (2000) Thymic neuroendocrine carcinomas with combined features ranging from welldifferentiated (carcinoid) to small cell carcinoma: A clinicopathologic and immunohistochemical study of 11 cases. Am J Clin Pathol 113 345-350.
306. VT De Montpreville, P Macchiarini and E Dulmet (1996) Thymic neuroendocrine carcinoma (carcinoid): A clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 111 134-141.
307. EZ Du, P Goldstraw, J Zacharias, et al. (2004) TTF-1 expression in specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 25 825-831.
308. AM Oliveira, HD Tazelaar, JL Myers, et al. (2001) Thyroid transcription factor-1 distinguishes metastatic pulmonary from welldifferentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25 815-819.
309. O Kaufmann and M Dietel (2000) Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 36 415-420.
310. CA Moran and S Suster (2000) Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 114 100-110.
311. T Hishima, M Fukayama, Y Hayashi, et al. (1998) Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Hum Pathol 29 330-338.
312. N Kimura, M Pilichowska, H Okamoto, et al. (2000) Immunohistochemical expression of chromogranins A and B, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod Pathol 13 140-146.
313. K Goto, T Kodama, Y Matsuno, et al. (2001) Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Mod Pathol 14 985-994.